Variant report

Variant	nsv1015468
Chromosome Location	chr9:115889-273160
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1915)
CpG islands
(count:976)
Chromatin interactive
region (count:84)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1915 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
2	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
3	ARID3A	chr9:210220-210873	K562	blood:	n/a	n/a
4	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
5	ARID3A	chr9:272095-272522	K562	blood:	n/a	n/a
6	ARID3A	chr9:272758-273406	K562	blood:	n/a	chr9:273064-273079
7	ARID3A	chr9:214214-215154	K562	blood:	n/a	n/a
8	ARID3A	chr9:215966-216247	K562	blood:	n/a	n/a
9	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
10	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
11	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
12	ATF1	chr9:272150-272512	K562	blood:	n/a	n/a
13	ATF1	chr9:272781-273161	K562	blood:	n/a	n/a
14	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
15	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
16	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
17	ATF1	chr9:211078-211816	K562	blood:	n/a	n/a
18	ATF2	chr9:272650-273286	GM12878	blood:	n/a	n/a
19	ATF2	chr9:272677-273240	GM12878	blood:	n/a	n/a
20	ATF3	chr9:210212-210461	K562	blood:	n/a	n/a
21	ATF3	chr9:272081-272576	K562	blood:	n/a	n/a
22	BACH1	chr9:214677-214706	H1-hESC	embryonic stem cell:	n/a	n/a
23	BACH1	chr9:207498-207603	K562	blood:	n/a	n/a
24	BACH1	chr9:214910-215270	H1-hESC	embryonic stem cell:	n/a	n/a
25	BATF	chr9:178645-179348	GM12878	blood:	n/a	chr9:179069-179082
26	BATF	chr9:185844-186146	GM12878	blood:	n/a	n/a
27	BATF	chr9:183522-184128	GM12878	blood:	n/a	n/a
28	BATF	chr9:167629-168111	GM12878	blood:	n/a	n/a
29	BATF	chr9:183636-184093	GM12878	blood:	n/a	n/a
30	BATF	chr9:167541-168102	GM12878	blood:	n/a	n/a
31	BATF	chr9:152906-153110	GM12878	blood:	n/a	chr9:152982-152993
32	BATF	chr9:198874-199092	GM12878	blood:	n/a	chr9:198886-198895
33	BATF	chr9:185826-186168	GM12878	blood:	n/a	n/a
34	BATF	chr9:184237-185449	GM12878	blood:	n/a	chr9:184501-184509
35	BATF	chr9:156926-157447	GM12878	blood:	n/a	n/a
36	BATF	chr9:164778-164998	GM12878	blood:	n/a	n/a
37	BATF	chr9:116510-116717	GM12878	blood:	n/a	n/a
38	BATF	chr9:122820-123095	GM12878	blood:	n/a	n/a
39	BATF	chr9:156921-157465	GM12878	blood:	n/a	n/a
40	BATF	chr9:184216-185020	GM12878	blood:	n/a	chr9:184501-184509
41	BATF	chr9:199639-200066	GM12878	blood:	n/a	n/a
42	BATF	chr9:177184-177383	GM12878	blood:	n/a	n/a
43	BATF	chr9:178036-178376	GM12878	blood:	n/a	n/a
44	BATF	chr9:178082-178323	GM12878	blood:	n/a	n/a
45	BATF	chr9:199669-200113	GM12878	blood:	n/a	n/a
46	BATF	chr9:200387-200708	GM12878	blood:	n/a	chr9:200519-200530
47	BATF	chr9:156635-156839	GM12878	blood:	n/a	n/a
48	BATF	chr9:178394-179363	GM12878	blood:	n/a	chr9:179069-179082
49	BATF	chr9:156608-156841	GM12878	blood:	n/a	n/a
50	BATF	chr9:198812-199262	GM12878	blood:	n/a	chr9:198886-198895

(count:976 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:273072-273122	HCF	heart:	n/a
2	chr9:179409-179459	HCT-116	colon:	n/a
3	chr9:117608-117658	Hela-S3	cervix:	n/a
4	chr9:215561-215611	ECC-1	luminal epithelium:	n/a
5	chr9:168828-168878	GM19239	blood:	n/a
6	chr9:179409-179459	H1-hESC	embryonic stem cell:	embryo
7	chr9:168828-168878	RPTEC	kidney:	n/a
8	chr9:213650-213700	Caco-2	colon:	n/a
9	chr9:118530-118580	PFSK-1	brain:	n/a
10	chr9:168828-168878	HNPCEpiC	eye:	n/a
11	chr9:213650-213700	HCPEpiC	choroid plexus:	n/a
12	chr9:176893-176943	HRE	kidney:	n/a
13	chr9:273072-273122	HPAEpiC	pulmonary alveolar:	n/a
14	chr9:213650-213700	GM12891	blood:	n/a
15	chr9:214690-214740	K562	blood:	n/a
16	chr9:168828-168878	H1-hESC	embryonic stem cell:	embryo
17	chr9:213650-213700	NHBE	bronchial:	n/a
18	chr9:118698-118748	HMEC	breast:	n/a
19	chr9:118091-118141	SK-N-SH_RA	brain:	n/a
20	chr9:117608-117658	T-47D	breast:	n/a
21	chr9:211689-211739	PrEC	prostate:	n/a
22	chr9:215368-215418	AG04450	lung:	fetal
23	chr9:211689-211739	Caco-2	colon:	n/a
24	chr9:211689-211739	A549	lung:	n/a
25	chr9:214268-214318	NH-A	brain:	n/a
26	chr9:211689-211739	HEEpiC	esophagus:	n/a
27	chr9:273072-273122	Hela-S3	cervix:	n/a
28	chr9:213650-213700	MCF10A-Er-Src	breast:	n/a
29	chr9:117044-117094	ECC-1	luminal epithelium:	n/a
30	chr9:214612-214662	NHDF-neo	bronchial:	n/a
31	chr9:118091-118141	BE2_C	brain:	n/a
32	chr9:168828-168878	Hepatocyte	liver:	n/a
33	chr9:118530-118580	HepG2	liver:	n/a
34	chr9:215561-215611	HRPEpiC	eye:	n/a
35	chr9:118530-118580	HNPCEpiC	eye:	n/a
36	chr9:118530-118580	BE2_C	brain:	n/a
37	chr9:214612-214662	ovcar-3	ovarian:	n/a
38	chr9:211689-211739	Hepatocyte	liver:	n/a
39	chr9:214268-214318	NHBE	bronchial:	n/a
40	chr9:179409-179459	CMK	blood:	n/a
41	chr9:273072-273122	GM06990	blood:	n/a
42	chr9:168828-168878	HPAEpiC	pulmonary alveolar:	n/a
43	chr9:214690-214740	HIPEpiC	eye:	n/a
44	chr9:214690-214740	AG09309	skin:	n/a
45	chr9:118698-118748	MCF-7	breast:	n/a
46	chr9:176893-176943	MCF10A-Er-Src	breast:	n/a
47	chr9:214612-214662	U87	brain:	n/a
48	chr9:117608-117658	HRCEpiC	kidney:	n/a
49	chr9:211689-211739	HCF	heart:	n/a
50	chr9:213650-213700	PFSK-1	brain:	n/a

(count:84 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr9:212468..215901-chr9:260350..263868,4	K562	blood:
2	chr9:217275..219531-chr9:301975..303827,2	MCF-7	breast:
3	chr9:211063..213249-chr9:216572..219831,3	K562	blood:
4	chr9:209849..211411-chr9:213516..215617,2	MCF-7	breast:
5	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
6	chr9:207715..211592-chr9:270281..275557,5	K562	blood:
7	chr9:264854..268401-chr9:271602..276392,5	K562	blood:
8	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
9	chr9:224695..226653-chr9:227779..229816,2	K562	blood:
10	chr9:243324..246093-chr9:246428..250809,6	K562	blood:
11	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
12	chr9:216842..219174-chr9:220888..224256,4	K562	blood:
13	chr9:211063..213249-chr9:216572..219831,3	K562	blood:
14	chr9:214285..216173-chr9:227690..229444,2	K562	blood:
15	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
16	chr9:253544..257279-chr9:268731..273892,6	K562	blood:
17	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
18	chr9:216842..219174-chr9:220888..224256,4	K562	blood:
19	chr9:213587..215367-chr9:247326..250011,2	MCF-7	breast:
20	chr9:257830..262248-chr9:271354..273884,5	K562	blood:
21	chr17:56717189..56717712-chr9:242303..242942,2	MCF-7	breast:
22	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
23	chr9:210795..213326-chr9:213922..216378,4	MCF-7	breast:
24	chr9:227507..229537-chr9:238867..240547,2	K562	blood:
25	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
26	chr9:213589..216422-chr9:270983..274599,7	K562	blood:
27	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
28	chr9:227507..229537-chr9:238867..240547,2	K562	blood:
29	chr9:224695..226653-chr9:227779..229816,2	K562	blood:
30	chr9:212545..218648-chr9:270340..281940,20	K562	blood:
31	chr9:250806..252981-chr9:269858..272236,2	MCF-7	breast:
32	chr9:255761..258409-chr9:263285..266102,2	K562	blood:
33	chr9:213410..215081-chr9:270583..272682,2	MCF-7	breast:
34	chr9:237104..239333-chr9:240417..242425,2	K562	blood:
35	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
36	chr9:258428..261727-chr9:265742..268870,3	K562	blood:
37	chr9:244363..245872-chr9:248878..250809,2	K562	blood:
38	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
39	chr9:223853..225771-chr9:261619..263535,2	K562	blood:
40	chr9:270180..272736-chr9:272837..274435,2	K562	blood:
41	chr9:239328..240900-chr9:247584..249872,2	K562	blood:
42	chr9:258428..261727-chr9:265742..268870,3	K562	blood:
43	chr9:268889..271022-chr9:277493..279614,2	K562	blood:
44	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
45	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
46	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
47	chr9:268983..271562-chr9:284279..286719,2	MCF-7	breast:
48	chr9:214856..218562-chr9:240584..242539,3	K562	blood:
49	chr9:207956..209819-chr9:211466..213662,2	MCF-7	breast:
50	chr9:211790..213319-chr9:241598..244495,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FOXD4-5	chr9:156481-156527	NONHSAT129910
2	lnc-FOXD4-5	chr9:151745-152078	NONHSAT129910
3	lnc-FOXD4-5	chr9:154709-154795	NONHSAT129910
4	lnc-C9orf66-1	chr9:272905-273002	ENSG00000235880.1
5	lnc-FOXD4-5	chr9:161567-161647	NONHSAT129910
6	lnc-C9orf66-1	chr9:267966-268273	ENSG00000235880.1

No data

Variant related genes	Relation type
DOCK8	TF binding region
ENSG00000231808	TF binding region
FOXD4	TF binding region
ENSG00000235880	TF binding region
CBWD1	TF binding region
C9orf66	TF binding region
DOCK8	CpG island
ENSG00000231808	CpG island
FOXD4	CpG island
ENSG00000235880	CpG island
CBWD1	CpG island
C9orf66	CpG island
ENSG00000101191	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000183784	chromatin interactions
ENSG00000107099	chromatin interactions

Extended variants
information (count: 6340 )
Associated
traits (count: 118 )

Variant overlapped rSNPs/rCNVs (count:6340 , 50 per page) page: 1 2 3 4 5 6 7 ... 127

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs372573669	chr9:115926-115927	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs375764556	chr9:115944-115945	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs559778894	chr9:115946-115947	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs62533586	chr9:115968-115969	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs62533587	chr9:115970-115971	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs201534074	chr9:115984-115985	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs201502877	chr9:116318-116319	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs570533249	chr9:116323-116324	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs534417886	chr9:116348-116349	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs546231043	chr9:116355-116356	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs567703051	chr9:116509-116510	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs536577064	chr9:116515-116516	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs554864655	chr9:116516-116517	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs576626079	chr9:116539-116540	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs71509932	chr9:116557-116558	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs537659485	chr9:116579-116580	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs558835286	chr9:116581-116582	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs577313264	chr9:116591-116592	Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs541524788	chr9:116622-116623	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs559817243	chr9:116633-116634	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs574910328	chr9:116641-116642	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs542213756	chr9:116649-116650	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs1665334	chr9:116719-116720	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs563610552	chr9:116735-116736	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs184811440	chr9:116744-116745	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs546026483	chr9:116747-116748	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs564118426	chr9:116756-116757	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs373774813	chr9:116773-116774	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs79220013	chr9:116800-116801	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs528223803	chr9:116804-116805	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs201375121	chr9:116809-116810	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs370289268	chr9:116811-116812	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs543503793	chr9:116814-116815	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs189230491	chr9:116815-116816	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs267602076	chr9:116828-116829	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs4742632	chr9:116832-116833	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs528874495	chr9:116837-116838	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs138181483	chr9:116840-116841	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs550119004	chr9:116841-116842	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs532235124	chr9:116848-116849	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs143746049	chr9:116861-116862	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs113240825	chr9:116873-116874	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs147228206	chr9:116874-116875	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs559143484	chr9:116897-116898	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs370502475	chr9:116911-116912	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs535147968	chr9:116931-116932	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs368083509	chr9:116936-116937	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs370647874	chr9:116938-116939	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs553522138	chr9:116950-116951	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs139850554	chr9:116953-116954	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:118)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Schizophrenia	23813976	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:1489 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:115200-116000	Weak transcription	Right Ventricle	heart
2	chr9:116400-116800	Bivalent Enhancer	GM12878-XiMat	blood
3	chr9:116400-117000	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
4	chr9:116400-117000	Bivalent Enhancer	Fetal Thymus	thymus
5	chr9:116600-116800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
6	chr9:116600-116800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
7	chr9:116600-116800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr9:116600-116800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
9	chr9:116600-116800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
10	chr9:116600-116800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
11	chr9:116600-116800	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
12	chr9:116600-117000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
13	chr9:116600-117000	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
14	chr9:116600-117000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
15	chr9:116600-117000	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
16	chr9:116600-117000	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
17	chr9:116600-117200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
18	chr9:116600-117600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
19	chr9:116600-117600	Bivalent Enhancer	Left Ventricle	heart
20	chr9:116600-118000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr9:116600-118400	Bivalent Enhancer	Primary B cells from peripheral blood	blood
22	chr9:116600-118600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
23	chr9:116800-117000	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
24	chr9:116800-117000	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr9:116800-117000	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
26	chr9:116800-117000	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr9:116800-117000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr9:116800-117000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells short term culture	blood
29	chr9:116800-117000	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
30	chr9:116800-117000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
31	chr9:116800-117000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr9:116800-117000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr9:116800-117000	Flanking Bivalent TSS/Enh	Colonic Mucosa	Colon
34	chr9:116800-117000	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
35	chr9:116800-117000	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
36	chr9:116800-117000	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
37	chr9:116800-117000	Bivalent Enhancer	Small Intestine	intestine
38	chr9:116800-117000	Enhancers	GM12878-XiMat	blood
39	chr9:116800-117400	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
40	chr9:116800-117400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
41	chr9:116800-117400	Bivalent Enhancer	Thymus	Thymus
42	chr9:116800-118200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
43	chr9:116800-118200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
44	chr9:116800-118200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
45	chr9:116800-118200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr9:116800-118200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr9:116800-118400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
48	chr9:116800-118600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
49	chr9:117000-117400	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
50	chr9:117000-118200	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links